|Bid||344.40 x 800|
|Ask||344.94 x 1000|
|Day's range||332.80 - 346.75|
|52-week range||172.05 - 552.00|
|Beta (5Y monthly)||1.56|
|PE ratio (TTM)||50.90|
|Earnings date||26 Apr 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||314.56|
There is perhaps no better example than Align Technology (NASDAQ: ALGN). It rocketed higher after an earnings report last week that left Wall Street thinking growth is getting back on track after it boomed -- and then collapsed -- through the pandemic.
TEMPE, Ariz., February 06, 2023--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("ASR") with Citibank, N.A. ("Citi"), to repurchase $250 million of Align's common stock under Align’s $
The stock shot up around 26% after reporting fourth-quarter results that were much better than expected.